EMA — authorised 25 October 2012
- Marketing authorisation holder: Takeda Pharma A/S
- Status: approved
🇪🇺 Adcetris in European Union
EMA authorised Adcetris on 25 October 2012
Marketing authorisation
Adcetris in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Adcetris approved in European Union?
Yes. EMA authorised it on 25 October 2012.
Who is the marketing authorisation holder for Adcetris in European Union?
Takeda Pharma A/S holds the EU marketing authorisation.